Tag | Content |
---|
EnhancerAtlas ID | HS023-07050 |
Organism | Homo sapiens |
Tissue/cell | CD8+ |
Coordinate | chr13:111377710-111379620 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Foxd3 | MA0041.1 | chr13:111378330-111378342 | GTTTGTTTGTTT | + | 6.32 | Nr2f6(var.2) | MA0728.1 | chr13:111378548-111378563 | TGAACTCCTGACCTC | - | 6.22 | PLAG1 | MA0163.1 | chr13:111379208-111379222 | GAGGCCCAAGGGTG | + | 6.31 | SNAI2 | MA0745.2 | chr13:111379341-111379351 | TGCACCTGTT | - | 6.02 | Zfx | MA0146.2 | chr13:111378573-111378587 | CCCGCCTCGGCCTC | + | 6.01 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_19894 | chr13:111378585-111379591 | CD4p_CD25-_Il17p_PMAstim_Th17 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr13 | 111378707 | 111379593 | chr13 | 111379072 | 111379409 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH13I110726 | chr13 | 111378642 | 111379588 |
|
Enhancer Sequence | ATTTTCTACG AAACAAGAAA ATGCTTGTTT CAGCAGGCAA CTTTAAATAA AGGTACTCAG 60 TGTCGTGGTG TATGTATATC AATATAGCCA CCATTTATTG CCTCCTATAT GCTAGACATT 120 GCTAGCACTG CATACTTCAT ATTTTATGAC AACCCTGCCA AAAAATGGCT GCTTTTCCTG 180 ATGAAGGTGC TGAGACTCCA GCCAGGGACC TGACTTGCAC AAGGCCAACG CCCTGCATCT 240 GGCTCCAAAA CCAGCATCCT TGACCACCGC CTGGCACCCG GAGGCCTCCT CATGGTCAGG 300 ACCTGGCGTT GCTGCTGGTC TTCCCTGAAC GCCTAACATG CCAGGAGTGT GCTGTCCTCC 360 CAGCTCTGTG GGGGTCTTAC AACTGAGAAA GCCATAGAAG GTGAAAGAAA CGCTCATGGT 420 CTCACGGGAG GAGAGAGCGA AAAAGTCTTA ATTGCTGGGC TTCTTTGCCT GAATGAAGGG 480 ATCTGCAGGA GCCACGGGTA TTTGCACTAC CAAGTTCTCA TGCTTCTGAT TTTCCTCCAG 540 GTAAACCAGG ATGCTTACTT CAAGTTTCTT GTTTTGCCCT ACAGTGAATT TTAGGATTGT 600 AATTTACCTG CAAGGTTTTT GTTTGTTTGT TTTGTTTTGT TTTTTCGAGA TGGAGTTTCG 660 CCCAAGCTGG AGTGCAATGG CGCAATCTCT GCTCACTGCA ACCTTCGCCT CCCGGGTTCA 720 AGCAATTCTC CTGCGTTAGC CACCCGAGTA GCTGGGATTA CAGGCACGCG CCACCACACC 780 TGGCTAATTT TGTATTTTTA GTAGAGACGG GGTTTCTCCA TGTTGGTGAG GCTGGTCTTG 840 AACTCCTGAC CTCAGGTGAT CCGCCCGCCT CGGCCTCCCA AAGTACTGGG ATTACAGGCA 900 TGAGCCACCG TGCCCAGCCT ACCTGCAAGG TTTTAAGCAA TTCACTAGGA GCCATGCACG 960 GTGCTAGAAT CAGCATGAGA GTCAAAGTCA GATTTGAATC AGGACTAGTT TATCACAGGT 1020 TAACCTCAAG GAAGTCACTC TTCTGTACCC AATGTTCTCA GAAGCAAAAT AAGGACAGTG 1080 ATAATGCCCA TCCCAGGAGT GGAGGCCCAG ACTTGTTAAT GTCTGAAAAT ACTTCAGAAA 1140 TGCTAGAGCA CTGTACAGAT AACAATTTGA GTAATATTTT TGGTCAAATT ATTCTAGTTT 1200 AACACATGTA TTCTTAAAAA ATGGACTTGT GATTCCTTAC AGCTAAAGAG AATCAAGTCC 1260 ACCCTTAGCA TGTTAGCGGT CACTGCCAGG TTCCTGCTGC ACGAGGAGGA AGTCCTCCAT 1320 GGCTGCTTTT CTATAAACAA TTCCATTTCT CGTTGTAGAA CACAGAAGTA AATACATCGA 1380 ATTTTTATTT TTAGTAGCAA TCAGAGCCTA CTAAACTTCC TTTTGACTCA CCTCTTGATT 1440 GAATTCAGAG TAGGCAGAAA ATCTCATTCA ATCTCTTCAC TGTGTGGGTG AGGAAACCGA 1500 GGCCCAAGGG TGATGAAGCC ACTTCCTCAA AGGCACTCCG TGAGTTGGTG GTGGGGCTGC 1560 CGGCAGGATG AAGTGCTGTT ACTCCAGGCC AGAGCCACTC CCCCGCTTCA TCAGCCATGC 1620 TGTTTCATGG GTGCACCTGT TCTCATTTAT GTGGACGTTA GGAACCGTGG GTCTCTCGTG 1680 TTAAGCCATA GGCCTTTAAT AAAGACGTGT AGAGTAAAGC CTGAATCCAA GAATTGACAT 1740 TTAAACATGA AACATTTTCT TTTCTAACTT GGAAACCAGT TCTAAAAACA CACCTAAAAG 1800 GGAATTTCAG TTTGATTTGT GTGAAGGGAA TATTTTTGGA TAAATCTGTA TGCCATTGGA 1860 AATGCAATAT TTCTAAATGA TTAATATTTG AGACATTAAT GTAATGAGAC 1910
|